These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12649081)

  • 1. Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway.
    Weis M; Cooke JP
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):567-75. PubMed ID: 12649081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide.
    Koglin J
    Z Kardiol; 2000; 89 Suppl 9():IX/24-7. PubMed ID: 11151787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation.
    Perrault LP; Bidouard JP; Janiak P; Villeneuve N; Bruneval P; Vilaine JP; Vanhoutte PM
    J Heart Lung Transplant; 1997 Jun; 16(6):643-57. PubMed ID: 9229295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endothelial function in coronary atherosclerosis and heart failure--the role of nitric oxide in regulation of vasomotor tone].
    Andreassen AK; Kirkebøen KA
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4066-9. PubMed ID: 10613099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart allograft endothelial cell dysfunction. Cause, course, and consequences.
    Weis M; Pehlivanli S; von Scheidt W
    Z Kardiol; 2000; 89 Suppl 9():IX/58-62. PubMed ID: 11151795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiogenic shock and coronary endothelial dysfunction predict cardiac allograft vasculopathy after heart transplantation.
    Lopez-Fernandez S; Manito-Lorite N; Gómez-Hospital JA; Roca J; Fontanillas C; Melgares-Moreno R; Azpitarte-Almagro J; Cequier-Fillat A
    Clin Transplant; 2014 Dec; 28(12):1393-401. PubMed ID: 25284267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting the NO pathway with intracoronary L-NAME infusion increases endothelial dysfunction and intimal hyperplasia after heart transplantation.
    Perrault LP; Malo O; Bidouard JP; Villeneuve N; Vilaine JP; Vanhoutte PM
    J Heart Lung Transplant; 2003 Apr; 22(4):439-51. PubMed ID: 12681422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis.
    Weis M; Kledal TN; Lin KY; Panchal SN; Gao SZ; Valantine HA; Mocarski ES; Cooke JP
    Circulation; 2004 Feb; 109(4):500-5. PubMed ID: 14732750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injury of the coronary endothelium at implantation increases endothelial dysfunction and intimal hyperplasia after heart transplantation.
    El-Hamamsy I; Stevens LM; Vanhoutte PM; Perrault LP
    J Heart Lung Transplant; 2005 Mar; 24(3):251-8. PubMed ID: 15737750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary endothelial dysfunction as a predictor of intimal thickening in the long term after heart transplantation.
    Martí V; Romeo I; Aymat R; García J; Guiteras P; Ballester M; Aminian N; Caralps JM; Augé JM
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1174-80. PubMed ID: 11726893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is atherosclerosis an arginine deficiency disease?
    Cooke JP
    J Investig Med; 1998 Oct; 46(8):377-80. PubMed ID: 9805422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.
    Moien-Afshari F; Choy JC; McManus BM; Laher I
    J Heart Lung Transplant; 2004 Feb; 23(2):193-203. PubMed ID: 14761767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction in cardiac allograft vasculopathy: potential pharmacological interventions.
    Osto E; Tona F; De Bon E; Iliceto S; Cella G
    Curr Vasc Pharmacol; 2010 Mar; 8(2):169-88. PubMed ID: 19485920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts.
    Egi K; Conrad NE; Kwan J; Schulze C; Schulz R; Wildhirt SM
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):262-9. PubMed ID: 15296881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium-smooth muscle interaction in cardiac transplantation.
    Skarsgard PL; McManus BM; van Breemen C; Laher I
    Clin Exp Pharmacol Physiol; 1998 Oct; 25(10):836-40. PubMed ID: 9784926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute rejection on L-arginine/iNOS pathway in canine heart transplantation.
    Demers P; Elkouri S; Sirois MG; Cartier R
    Can J Cardiol; 2003 Mar; 19(4):419-25. PubMed ID: 12704490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coronary endothelial dysfunction and graft atheromatosis following heart transplantation].
    Vassalli G
    Schweiz Med Wochenschr; 1995 Oct; 125(41):1923-30. PubMed ID: 7481650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences].
    Patti G; Melfi R; Di Sciascio G
    Recenti Prog Med; 2005 Oct; 96(10):499-507. PubMed ID: 16491775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endothelial dysfunction: a global response].
    López-Farré A; Farré J; Sánchez de Miguel L; Romero J; González-Fernández F; Casado S
    Rev Esp Cardiol; 1998; 51 Suppl 6():18-22. PubMed ID: 10050140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus.
    Shemyakin A; Kövamees O; Rafnsson A; Böhm F; Svenarud P; Settergren M; Jung C; Pernow J
    Circulation; 2012 Dec; 126(25):2943-50. PubMed ID: 23183942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.